Verified peer comparison
Melar Acquisition Corp. I - Class A Ordinary Shares vs Seres Therapeutics, Inc. Financial Comparison
Melar Acquisition Corp. I - Class A Ordinary Shares versus Seres Therapeutics,…
Direct answer
Melar Acquisition Corp. I - Class A Ordinary Shares and Seres Therapeutics, Inc. are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Melar Acquisition Corp. I - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Melar Acquisition Corp. I - Class A Ordinary Shares Revenue
- 0 USD
- Seres Therapeutics, Inc. Revenue
- 789,000 USD
- Melar Acquisition Corp. I - Class A Ordinary Shares Operating income
- -1,475,992 USD
- Seres Therapeutics, Inc. Operating income
- -93,971,000 USD